ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Videos Hematologic Malignancies

Videos Hematologic Malignancies

This video reviews results of the ZUMA-1 trial, which tested the CAR T-cell therapy axicabtagene ciloleucel in patients with advanced non-Hodgkin lymphoma.

This video reviews results of the phase II CHRONOS-1 trial, a single-arm study evaluating the investigational agent copanlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.

This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes.

This video explores the current treatment landscape for lower-risk MDS patients, including the various agents and sequencing strategies employed to best optimize outcomes.

This video examines frontline treatment options for patients with newly diagnosed chronic lymphocytic leukemia, including considerations for when chemotherapy or ibrutinib might be more appropriate.

This video examines the evolution in treatment and survival outcomes for patients with follicular lymphoma and highlights trials testing newer agents such as immunotherapies in this population.

This video examines a phase I/II study of ibrutinib in patients with chronic GVHD who failed corticosteroids.

Pages

Subscribe to Videos Hematologic Malignancies on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.